Ubs Global Asset Management Americas »

Janux Therapeutics shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2024-03-31 $327k 8.7k 37.65

More positions owned by Ubs Global Asset Management Americas

Microsoft Corp Equity Us Cm (MSFT)
Apple Equity Us Cm (AAPL)
Nvidia Corp Equity Us Cm (NVDA)
Amazon Equity Us Cm (AMZN)
Alphabet Inc Cl A Equity Us Cm (GOOGL)
Meta Platforms Equity Us Cm (META)
Ishares Core Msci Eafe Equity (IEFA)
Alphabet Inc Cl C Equity Us Cm (GOOG)
Eli Lilly &#38 Equity Us Cm (LLY)
Broadcom Equity Us Cm (AVGO)
Tesla Equity Us Cm (TSLA)
Unitedhealth Group Equity Us Cm (UNH)
Advanced Micro Devices Equity Us Cm (AMD)
Visa Inc Class A Shares Equity Us Cm (V)
Jpmorgan Chase &#38 Company Equity Us Cm (JPM)

View all positions for Ubs Global Asset Management Americas

Top funds holding Janux Therapeutics

RA Capital Management
FMR
OrbiMed Advisors
BVF
Adage Capital Partners GP
Citadel Advisors
Henderson Group
BlackRock
Vanguard Group
Rtw Investments
Cormorant Asset Management
Lord, Abbett & Co
Geode Capital Management
State Street Corporation
Avidity Partners Management

View all funds holding Janux Therapeutics